Skip to content
New: free dose calculator with 14 peptide presets. No signup.
Peptides Academy

GLP-1 Agonist + Tesamorelin Liver-Metabolic Stack

This pairing targets fatty liver and visceral adiposity from two complementary angles: a GLP-1 (or GLP-1/GIP) agonist drives whole-body weight loss and improves insulin sensitivity, while tesamorelin's GHRH mechanism preferentially mobilizes visceral fat, the depot most tightly linked to hepatic steatosis. Both approaches reduce liver fat, but through partly distinct routes.

Quick Comparison

PropertypeptideThe Liver-Metabolic Stack: GLP-1 + Tesamorelin
SourceSalmon DNA fragmentsVarious sources
Primary MechanismA2A receptor activation, DNA repairVaries by ingredient
Key BenefitsTissue regeneration, anti-inflammation, collagen boostMultiple skin benefits
Best Time to ApplyAM or PMAM or PM
Can Combine?Generally compatible — check specific guidelines.

How to Use Together

GLP-1 agonists (semaglutide, or tirzepatide as a GLP-1/GIP agent) are dosed by weekly subcutaneous injection with gradual escalation to manage gastrointestinal side effects. Tesamorelin is administered by daily subcutaneous injection, typically in the evening to align with the natural GH pulse. The two operate through independent mechanisms and do not require special timing coordination, though both should be introduced sequentially rather than simultaneously so tolerability and side effects can be attributed correctly. This stack is a clinical concept and should only be used under medical supervision with appropriate metabolic and liver monitoring.

Safety Notes

GLP-1 agonists commonly cause nausea, reduced appetite, and other GI effects, carry a rodent thyroid C-cell tumor warning (contraindicated with personal/family history of medullary thyroid carcinoma or MEN2), and require attention to the significant lean-mass loss that accompanies rapid weight loss. Tesamorelin raises IGF-1 and can transiently affect insulin sensitivity, so glucose should be monitored, and it is contraindicated in active malignancy. Combining two agents that both influence glucose metabolism increases the importance of monitoring. Fatty liver disease also mandates ruling out other liver-disease causes and continuing standard-of-care lifestyle measures. This combination is investigational as a stack and is not a substitute for medical care.

Recommended Products (3)

Frequently Asked Questions

Why combine a GLP-1 agonist with tesamorelin for liver fat?
They reduce liver fat through partly different routes. GLP-1 (and GLP-1/GIP) agonists lower liver fat mainly by driving whole-body weight loss and improving insulin sensitivity, with the strongest biopsy-based data in MASH. Tesamorelin's GHRH mechanism preferentially mobilizes visceral adipose tissue, the depot most closely tied to hepatic steatosis, and has data showing reduced hepatic fat fraction. The rationale is complementary depot targeting.
Is this stack proven to work together?
No. Each agent has individual evidence for reducing liver and/or visceral fat, but the combination has not been formally studied as a stack in controlled trials. It is a mechanistically coherent concept, not a validated protocol, and should be treated as investigational.
Does this replace lifestyle treatment for fatty liver?
No. Weight loss of 7–10% of body weight through diet and activity remains the foundation of fatty liver (MASLD/MASH) treatment and can regress early fibrosis. These peptides can help achieve and sustain metabolic improvement, but they complement rather than replace lifestyle change, alcohol reduction, and glycemic control.
Would tirzepatide alone be simpler than adding tesamorelin?
Often, yes. Tirzepatide produces substantial weight loss and strong liver-fat reductions on its own, and for many people a single well-tolerated agent is preferable to a two-drug stack. Tesamorelin is most relevant when visceral fat is the specific concern — for example the metabolically obese, normal-weight phenotype — or when additional visceral-fat reduction is sought under supervision.
What monitoring does this stack require?
A clinician-directed panel typically includes liver enzymes and imaging-based liver fat assessment (such as MRI-PDFF or elastography), fasting glucose and HbA1c, IGF-1 (for tesamorelin), lipid profile, and body-composition tracking to watch for lean-mass loss. Baseline evaluation to exclude other liver-disease causes is essential before starting.

Other peptide Ingredient Combinations

The Anti-Aging Stack: GHK-Cu + Epitalon

GHK-Cu and Epitalon target two distinct hallmarks of aging — extracellular matrix degradation and te

The Athletic Performance Stack: IGF-1 LR3 + Ipamorelin + BPC-157

The athletic performance stack layers three peptides with distinct but complementary mechanisms to s

The Autoimmune Stack: KPV + BPC-157 + Thymosin Alpha-1 + Low-Dose Naltrexone

A four-component protocol addressing autoimmune dysregulation through complementary immunomodulatory

The Bone Health Stack: BPC-157 + Abaloparatide + Collagen Peptides

A three-component protocol addressing bone mineral density and bone quality. Abaloparatide is a synt

The Cardiac Protection Stack: TB-500 + SS-31 + Humanin

A three-peptide cardiovascular support stack targeting myocardial repair (TB-500), mitochondrial car

The Circadian Reset Stack: DSIP + Epitalon

This pairing targets sleep and circadian regulation from two angles: DSIP (delta sleep-inducing pept

The Cognitive Stack: Semax + Selank

The classic Russian nootropic peptide pairing. Semax (an ACTH 4-10 analog) enhances BDNF expression

The Detox Support Stack: BPC-157 + KPV + LL-37 + Larazotide

A four-peptide combination addressing gut barrier integrity, systemic inflammation, and antimicrobia

The Endurance Stack: MOTS-c + SS-31 + BPC-157 + AOD-9604

A community-derived peptide combination discussed by endurance athletes for mitochondrial capacity,

The Eye Health Stack: Thymosin Beta-4 + BPC-157 + SS-31 + GHK-Cu

A theoretical peptide combination discussed for ocular surface and retinal support — dry eye, cornea

The Fat Loss Stack: Tesamorelin + CJC-1295/Ipamorelin

Tesamorelin and CJC-1295/Ipamorelin both target the GH axis but through complementary timing and rec

The Fertility Stack: Kisspeptin-10 + Gonadorelin + Oxytocin

A three-peptide protocol targeting the hypothalamic-pituitary-gonadal (HPG) axis at multiple levels.

The GH Stack: CJC-1295 + Ipamorelin

The dual-pathway growth-hormone stack. CJC-1295 (GHRH analog) opens the pituitary somatotroph; Ipamo

The Gut-Brain Stack: BPC-157 + KPV + Selank + Larazotide

A community-derived peptide combination built around the gut-brain axis — pairing intestinal barrier

The Gut Healing Stack: BPC-157 + KPV + Larazotide

The gut healing stack combines three peptides targeting distinct aspects of intestinal repair: BPC-1

The Hair Restoration Stack: GHK-Cu + Thymosin Beta-4

GHK-Cu and Thymosin Beta-4 (TB-500) target complementary mechanisms in hair follicle biology — coppe

The Healing Stack: BPC-157 + TB-500

The canonical regenerative-peptide pairing. BPC-157 and TB-500 operate through non-overlapping biolo

Immune Support Stack

A combination approach targeting immune function through three complementary mechanisms: adaptive im

The Joint Repair Stack: BPC-157 + Pentosan Polysulfate + TB-500

A comprehensive joint-repair protocol targeting all layers of joint pathology: BPC-157 for periartic

The Ligament Repair Stack: BPC-157 + TB-500 + Collagen

This is the most common connective-tissue 'injury stack' in anecdotal practice: BPC-157 for its angi

The Longevity Stack: Epitalon + MOTS-c + SS-31

Three peptides targeting different hallmarks of aging: Epitalon for telomerase activation and pineal

The Men's Hormone Stack: CJC-1295/Ipamorelin + Gonadorelin + Kisspeptin-10

A three-peptide protocol designed to optimize the male hormonal axis without exogenous testosterone.

The Menopause Support Stack: Kisspeptin-10 + Epitalon + BPC-157 + GHK-Cu

A community-derived peptide combination sometimes discussed for the constellation of complaints arou

The Metabolic Stack: GLP-1 + GHS

A newer 'metabolic recomposition' pairing some practitioners use: a GLP-1 agonist for appetite and t

The Mitochondrial Stack: SS-31 + MOTS-c + Humanin

Three mitochondria-targeted peptides addressing different aspects of mitochondrial dysfunction. SS-3

The Mood & Anxiety Stack: Selank + NA-Selank-Amidate + DSIP + Oxytocin

A four-peptide anxiolytic and mood-stabilizing protocol. Selank modulates GABA and serotonin signali

The Neuroprotection Stack: Cerebrolysin + Semax + Pinealon

The neuroprotection stack combines three neuropeptide approaches with complementary mechanisms — cer

The Nootropic Stack: Semax + Selank + GH-Axis Support

A three-tier nootropic peptide stack targeting cognitive performance through complementary mechanism

The Post-Surgery Recovery Stack: BPC-157 + TB-500 + Thymosin Alpha-1

The post-surgery recovery stack combines the established BPC-157 + TB-500 tissue-repair pairing with

The Sexual Health Stack: PT-141 + Kisspeptin-10

PT-141 and Kisspeptin-10 target complementary aspects of sexual function — central desire pathways a

The Skin Rejuvenation Stack: GHK-Cu + GH-Axis + Collagen

A multi-level skin rejuvenation protocol combining topical signaling (GHK-Cu), systemic GH-axis elev

The Sleep Stack: DSIP + Ipamorelin

DSIP (Delta Sleep-Inducing Peptide) and ipamorelin target complementary aspects of sleep optimizatio

The Stress Resilience Stack: Selank + DSIP + Semax

A three-peptide stack targeting different dimensions of the stress response: Selank for anxiolysis a

The Tendon Repair Stack: BPC-157 + TB-500 + GHK-Cu

A three-peptide protocol targeting tendon biology specifically. BPC-157 upregulates growth hormone r

The Thymic Regeneration Stack: Thymosin Alpha-1 + Thymalin + Thymulin

Three thymic peptides targeting the age-related involution of the thymus gland. Thymosin alpha-1 enh

The Vascular Health Stack: BPC-157 + SS-31 + Angiotensin-1-7 + MOTS-c

A theoretical peptide combination discussed for endothelial and circulatory support — pairing angiog

The Weight Loss Stack: Semaglutide/Tirzepatide + Tesamorelin

This weight loss stack combines GLP-1 receptor agonist therapy (semaglutide or tirzepatide) with the

The Women's Hormonal Stack: Kisspeptin + BPC-157 + Thymosin Alpha-1

A three-peptide combination addressing women's hormonal health through hypothalamic signaling restor

The Wound Care Stack: BPC-157 + GHK-Cu + TB-500 + Collagen Peptides

A four-component protocol covering the full wound healing cascade. BPC-157 promotes angiogenesis and

Browse All peptide Products

Search

Search across products, blog posts, wiki articles, and more.